These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8381558)

  • 21. The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort study.
    Laaksonen MA; Arriaga ME; Canfell K; MacInnis RJ; Byles JE; Banks E; Shaw JE; Mitchell P; Giles GG; Magliano DJ; Gill TK; Klaes E; Velentzis LS; Hirani V; Cumming RG; Vajdic CM
    Gynecol Oncol; 2019 Jun; 153(3):580-588. PubMed ID: 30935715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary. A brief overview.
    Kelsey JL; Whittemore AS
    Ann Epidemiol; 1994 Mar; 4(2):89-95. PubMed ID: 8205289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoprevention options for BRCA1 and BRCA2 mutation carriers.
    Eeles RA; Powles TJ
    J Clin Oncol; 2000 Nov; 18(21 Suppl):93S-9S. PubMed ID: 11060334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
    Bernstein L
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers.
    Karlsson T; Johansson T; Höglund J; Ek WE; Johansson Å
    Cancer Res; 2021 Feb; 81(4):1153-1162. PubMed ID: 33334812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Despite positive studies, popularity of chemoprevention drugs increasing slowly.
    Zielinski SL
    J Natl Cancer Inst; 2004 Oct; 96(19):1410-2. PubMed ID: 15467023
    [No Abstract]   [Full Text] [Related]  

  • 27. Does HRT modify risk of gynecological cancers?
    Schneider HP; Birkhauser M
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():40-53. PubMed ID: 7581588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian and endometrial cancers.
    Mant JW; Vessey MP
    Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology, prevention, and early detection of breast cancer.
    Daudt A; Alberg AJ; Helzlsouer KJ
    Curr Opin Oncol; 1996 Nov; 8(6):455-61. PubMed ID: 8971464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can chemoprevention reduce the risk of prostate cancer?
    Diamandis EP
    Clin Chem; 2010 Aug; 56(8):1214-5. PubMed ID: 20567025
    [No Abstract]   [Full Text] [Related]  

  • 31. Cancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy.
    Jordan SJ; Wilson LF; Nagle CM; Green AC; Olsen CM; Bain CJ; Pandeya N; Whiteman DC; Webb PM
    Aust N Z J Public Health; 2015 Oct; 39(5):434-40. PubMed ID: 26437728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone replacement therapy and the risk of reproductive cancers.
    Swan SH
    J Psychosom Obstet Gynaecol; 1997 Jun; 18(2):165-74. PubMed ID: 9219113
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemoprevention of prostate cancer: guidelines for possible intervention strategies.
    Crawford ED; Fair WR; Kelloff GJ; Lieber MM; Miller GJ; Scardíno PT; DeAntoni EP
    J Cell Biochem Suppl; 1992; 16H():140-5. PubMed ID: 1337764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1992 Sep; 268(11):1390. PubMed ID: 1380995
    [No Abstract]   [Full Text] [Related]  

  • 35. [Oral contraception and its beneficial gynecological effects].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospects for Chemoprevention of Cancers of the Cervix, Endometrium and Ovary: Surrogate Endpoints and Design of Clinical Trials. Conference proceedings. Oxnard, California, February 1-5, 1995.
    J Cell Biochem Suppl; 1995; 23():1-250. PubMed ID: 8786651
    [No Abstract]   [Full Text] [Related]  

  • 37. Hormone replacement therapy and female malignancy: what has the Million Women Study added to our knowledge?
    Marsden J
    J Fam Plann Reprod Health Care; 2007 Oct; 33(4):237-43. PubMed ID: 17925102
    [No Abstract]   [Full Text] [Related]  

  • 38. The tamoxifen dilemma.
    White IN
    Carcinogenesis; 1999 Jul; 20(7):1153-60. PubMed ID: 10383884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing prostate cancer: new analyses put finasteride back on the map.
    Vastag B
    J Natl Cancer Inst; 2008 Aug; 100(16):1132-3. PubMed ID: 18695128
    [No Abstract]   [Full Text] [Related]  

  • 40. Relationship of hormone use to cancer risk.
    Bernstein L; Ross RK; Henderson BE
    J Natl Cancer Inst Monogr; 1992; (12):137-47. PubMed ID: 1616798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.